Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.96 USD | -1.90% | +0.91% | +2.08% |
05-08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
05-08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.08% | 1.9B | |
+24.22% | 46.71B | |
+48.83% | 41.8B | |
-1.02% | 41.52B | |
-5.86% | 29.55B | |
+11.15% | 25.78B | |
-20.97% | 19.26B | |
+2.91% | 12.14B | |
-2.38% | 12.08B | |
+30.30% | 11.98B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Says FDA Grants Priority Review to New Drug Application for Acute Leukemia Treatment